Skip to content
Clinical Trials – home

Cork University Hospital

Verifiedinfo

Ireland Wilton, T12 DC4A Cork, Ireland

  • 52 trials recruiting
  • Breast cancer · Non-small cell lung cancer · Fallopian tube cancer
  • Adults and children

About Specializations

Cork University Hospital in Cork, Ireland specialises in clinical trials of conditions such as Breast cancer, Non-small cell lung cancer, Fallopian tube cancer, Ovarian cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology (Neoplasms)

Cork University Hospital’s oncology program is testing innovative therapies for breast cancer. It also evaluates new approaches for lung cancer and advances treatment options for other solid tumours.

  • Breast cancer
  • Lung cancer
  • Prostate cancer
  • Ovarian cancer
  • Colorectal cancer
  • Bladder cancer
  • Melanoma
  • Head and neck cancer
  • Gastric cancer
  • Urothelial carcinoma

Trials focus on evaluating targeted agents, immunotherapies and adjuvant strategies to improve survival and quality of life for patients with these malignancies.

Hematology & Blood Disorders

The department conducts studies on blood‑related cancers, including acute lymphoblastic leukaemia and multiple myeloma, aiming to discover more effective treatments.

  • Acute lymphoblastic leukaemia
  • Acute myeloid leukaemia
  • Mantle cell lymphoma
  • Multiple myeloma
  • Myelodysplastic syndromes
  • Polycythemia vera
  • Myelofibrosis
  • Chronic lymphocytic leukemia
  • AL amyloidosis

Research includes novel antibodies, cellular therapies and disease‑modifying agents to enhance remission rates and reduce relapse.

Respiratory and Infectious Diseases

Clinical trials address chronic lung conditions such as asthma and chronic obstructive pulmonary disease, as well as emerging infections like COVID‑19.

  • Asthma
  • Chronic obstructive pulmonary disease
  • Cystic fibrosis
  • COVID‑19
  • Mpox infection
  • Severe eosinophilic asthma
  • Bronchiectasis
  • Idiopathic pulmonary fibrosis
  • Respiratory tract infection

The aim is to improve lung function, reduce exacerbations, and evaluate antiviral or anti‑inflammatory therapies for better patient outcomes.

Renal and Urogenital Research

Studies target kidney diseases, with a focus on reducing proteinuria in conditions like IgA nephropathy and exploring treatments for primary membranous nephropathy.

  • IgA nephropathy
  • Primary membranous nephropathy
  • Nephrotic syndrome
  • Renal cell carcinoma
  • Venous thromboembolism in cancer patients
  • Kidney disease associated with multiple myeloma

These trials aim to preserve renal function, decrease protein loss and assess the safety of emerging therapies.

Immune System and Autoimmune Disorders

Research includes inflammatory and autoimmune conditions such as polymyalgia rheumatica and atopic dermatitis, testing new biologic agents.

  • Polymyalgia rheumatica
  • Atopic dermatitis
  • Eosinophilic asthma
  • Systemic mastocytosis
  • Other immune‑mediated diseases

The goal is to evaluate efficacy of immune‑modulating drugs and improve symptom control and disease remission.

Female Urogenital and Reproductive Health

Trials focus on gynecologic cancers, including ovarian cancer and cervical cancer, to develop better targeted and adjuvant therapies.

  • Ovarian cancer
  • Fallopian tube cancer
  • Cervical cancer
  • Endometrial cancer
  • High‑risk HER2‑positive breast cancer (female cohort)
  • Pregnancy‑related complications

These studies aim to improve survival, reduce recurrence and personalize treatment for women affected by these conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
WiltonT12 DC4A CorkIreland
Recruiting now
52 trials
Conditions studied
103
Partner status
Verified

More sites in CorkIreland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

133 clinical trials

Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:IrelandIreland
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Bronchiectasis

Recruiting
Investigational
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:IrelandIreland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:VAMIFEPORT TRIHYDROCHLORIDE
  • Sponsor:CSL Behring LLC
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5335
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.